Blood thinner dabigatran slows osteoarthritis in mouse and monkey models, with cartilage about 60% thicker in treated monkeys
Dabigatran targets BIG2 to inhibit TNF-α and IL-1β signaling, reducing inflammation and protecting against osteoarthritis in rodents and primates.